{"id":6410,"date":"2026-10-19T09:48:52","date_gmt":"2026-10-19T09:48:52","guid":{"rendered":"https:\/\/phd.hi.is\/doktorsvorn\/doktorsvorn-i-laeknavisindum-inga-lara-ingvarsdottir\/"},"modified":"2026-10-19T09:48:52","modified_gmt":"2026-10-19T09:48:52","slug":"doktorsvorn-i-laeknavisindum-inga-lara-ingvarsdottir","status":"publish","type":"phd_defence","link":"https:\/\/phd.hi.is\/en\/doktorsvorn\/doktorsvorn-i-laeknavisindum-inga-lara-ingvarsdottir\/","title":{"rendered":"Doktorsv\u00f6rn \u00ed l\u00e6knav\u00edsindum &#8211; Inga L\u00e1ra Ingvarsd\u00f3ttir"},"content":{"rendered":"<div class=\"field-items\">\n<div class=\"field-item even\" property=\"content:encoded\">\n<p>F\u00f6studaginn 27. j\u00fan\u00ed 2025 ver Inga L\u00e1ra Ingvarsd\u00f3ttir doktorsritger\u00f0 s\u00edna \u00ed l\u00e6knav\u00edsindum vi\u00f0 L\u00e6knadeild H\u00e1sk\u00f3la \u00cdslands. Ritger\u00f0in ber heiti\u00f0:<strong> Hjarta- og lungnad\u00e6lur:\u00a0 \u00c1bendingar og snemm- og s\u00ed\u00f0b\u00fainn \u00e1rangur. Extracorporeal membrane oxygenation:\u00a0 Indications and early and late outcome.<\/strong><\/p>\n<p>Andm\u00e6lendur eru dr. Jan van der Linden, pr\u00f3fessor vi\u00f0 Karolinska sj\u00fakrah\u00fasi\u00f0 \u00ed Sv\u00ed\u00fej\u00f3\u00f0, og dr. Julie Vishram-Nielsen, pr\u00f3fessor vi\u00f0 Zealand University Hospital \u00ed Danm\u00f6rku.<\/p>\n<p>Umsj\u00f3narkennari og lei\u00f0beinandi var T\u00f3mas Gu\u00f0bjartsson, pr\u00f3fessor. Auk hans s\u00e1tu \u00ed doktorsnefnd G\u00f6ran Dellgren, pr\u00f3fessor sem einnig var me\u00f0lei\u00f0beinandi Ingu L\u00e1ru \u00ed Gautaborg, Martin Ingi Sigur\u00f0sson, pr\u00f3fessor, Sigur\u00f0ur Ragnarsson, hjarta-og lungnaskur\u00f0l\u00e6knir og S\u00f3lveig Helgad\u00f3ttir, sv\u00e6finga-og gj\u00f6rg\u00e6slul\u00e6knir.<\/p>\n<p>\u00de\u00f3rarinn Gu\u00f0j\u00f3nsson, pr\u00f3fessor og \u00a0deildarforseti L\u00e6knadeildar, stj\u00f3rnar ath\u00f6fninni sem fer fram \u00ed H\u00e1t\u00ed\u00f0asal H\u00e1sk\u00f3la \u00cdslands og hefst kl. 9.<\/p>\n<p><strong>\u00c1grip<\/strong><\/p>\n<p>Hjarta- og\/e\u00f0a lungnad\u00e6la (ECMO) er l\u00edfsbjargandi me\u00f0fer\u00f0 sem h\u00e6gt er a\u00f0 beita \u00ed alvarlegri hjarta- og\/e\u00f0a \u00f6ndunarbilun og felur \u00ed s\u00e9r \u00ed st\u00f3rum dr\u00e1ttum a\u00f0 bl\u00f3\u00f0i\u00f0 er s\u00farefnisv\u00e6tt me\u00f0 gervilunga utan l\u00edkamans. Markmi\u00f0 ranns\u00f3kna I og II var a\u00f0 kanna \u00e1bendingar og \u00e1rangur d\u00e6lume\u00f0fer\u00f0ar h\u00e9r \u00e1 landi, \u00fear me\u00f0 tali\u00f0 langt\u00edma\u00e1rangur. A\u00f0 auki var markmi\u00f0i\u00f0 a\u00f0 kanna eins \u00e1rs \u00e1rangur me\u00f0fer\u00f0ar me\u00f0 hjartad\u00e6lu vegna hjartalosts \u00e1 st\u00e6rra h\u00e1sk\u00f3lasj\u00fakrah\u00fasi \u00ed Sv\u00ed\u00fej\u00f3\u00f0, \u00fear sem einnig voru kanna\u00f0ar orsakir og alvarleiki hjartalostsins. Var \u00feetta gert me\u00f0 afturskyggnum ranns\u00f3knum \u00e1 \u00edslenskum d\u00e6lutilfellum \u00e1rin 1991-2022, og s\u00ed\u00f0ar eftirfylgd \u00e1 l\u00edfsg\u00e6\u00f0um \u00feeirra sj\u00faklinga sem voru \u00e1 l\u00edfi \u00e1rin 2022-2023. A\u00f0rar tv\u00e6r afturskyggnar ranns\u00f3knir (III og IV) voru ger\u00f0ar \u00e1 hjartad\u00e6lutilfellum \u00e1 Sahlgrenska sj\u00fakrah\u00fasinu \u00ed Gautaborg \u00e1rin 2004-2019. Ni\u00f0urst\u00f6\u00f0ur ranns\u00f3kna I og II benda til \u00feess a\u00f0 h\u00e6gt s\u00e9 a\u00f0 veita me\u00f0fer\u00f0 me\u00f0 hjarta- og lungnad\u00e6lu me\u00f0 \u00e1s\u00e6ttanlegum \u00e1rangri \u00e1 l\u00edtilli og einangra\u00f0ri einingu, eins og \u00e1 Landsp\u00edtala. \u00de\u00f3 eru t\u00e6kif\u00e6ri til b\u00e6tingar, m.a. hva\u00f0 var\u00f0ar val \u00e1 sj\u00faklingum \u00ed hjartad\u00e6lume\u00f0fer\u00f0 \u00ed hjartastoppi. \u00de\u00e1 s\u00fdndu ranns\u00f3knir III og IV a\u00f0 eins \u00e1rs lifun sj\u00faklinga sem fengu hjartad\u00e6lu vegna hjartalosts \u00e1 Sahlgrenska sj\u00fakrah\u00fasinu var \u00e1s\u00e6ttanleg og var \u00e1rangur bestur fyrir sj\u00faklinga me\u00f0 hjartabilun \u00e1n bl\u00f3\u00f0\u00feurr\u00f0arsj\u00fakd\u00f3ms. Verri horfur \u00feeirra sj\u00faklinga sem f\u00e1 hjartad\u00e6lu \u00ed hjartastoppi gefa til kynna mikilv\u00e6gi r\u00e9ttrar t\u00edmasetningar me\u00f0fer\u00f0arinnar, sem og r\u00e9tts sj\u00faklingavals.<\/p>\n<p><strong>Abstract <\/strong><\/p>\n<p>Extracorporeal membrane oxygenation (ECMO) is a form of life support used in severe and refractory respiratory and\/or cardiac failure. It includes oxygenating the blood with an artificial lung outside of the body. The aim of studies I and II was to examine the indications and outcome of ECMO in Iceland, including long-term outcome. Additionally, the aim in studies III and IV was to describe the 1-year outcome of venoarterial ECMO for cardiogenic shock in a larger Swedish center, with a focus on the etiology and the severity of the shock. This was achieved with retrospective studies on all adult venoarteral and venovenous ECMO patients treated in Iceland between 1991 and 2022, with a follow-up questionnaire for those that were alive in the years 2022-2023.\u00a0 Studies III and IV were also retrospective single-center studies, on all patients that received VA ECMO for cardiogenic shock at Sahlgrenska in the years 2004-2019. The results of studies I and II indicate that ECMO can be provided with an acceptable outcome in a low-volume and geographically isolated center, such as Landspitali. However, opportunities for improvement could be identified, such as stricter indications for ECMO in cardiac arrest. Additionally, 1-year survival was acceptable for patients receiving VA ECMO for cardiogenic shock at Sahlgrenska, with the most favorable outcome for patients with non-ischemic cardiomyopathies. Poorer outcome for patients receiving ECMO for cardiac arrest imply the importance of timing of the ECMO treatment of all etiologies, as well as patient selection.<\/p>\n<p><strong>Um doktorsefni\u00f0<\/strong><\/p>\n<p>Inga L\u00e1ra Ingvarsd\u00f3ttir er f\u00e6dd 1983 \u00ed Reykjav\u00edk. H\u00fan lauk kand\u00eddatspr\u00f3fi \u00ed l\u00e6knisfr\u00e6\u00f0i fr\u00e1 H\u00e1sk\u00f3la \u00cdslands \u00e1ri\u00f0 2010 og f\u00e9kk l\u00e6kningaleyfi a\u00f0 loknu kand\u00eddats\u00e1ri 2011. \u00c1ri\u00f0 2015 h\u00e9lt h\u00fan til frekara n\u00e1ms \u00ed Gautaborg og hlaut s\u00e9rfr\u00e6\u00f0ir\u00e9ttindi \u00ed sv\u00e6finga- og gj\u00f6rg\u00e6slul\u00e6kningum \u00e1ri\u00f0 2020. Fr\u00e1 \u00e1rinu 2022 hefur Inga L\u00e1ra starfa\u00f0 sem sv\u00e6finga- og gj\u00f6rg\u00e6slul\u00e6knir \u00e1 Landsp\u00edtala. Doktorsverkefni\u00f0 var unni\u00f0 samhli\u00f0a kl\u00edn\u00edskri vinnu vi\u00f0 Landsp\u00edtala og Sahlgrenska h\u00e1sk\u00f3lasj\u00fakrah\u00fasi\u00f0 \u00ed Gautaborg. Foreldrar Ingu L\u00e1ru eru Ingibj\u00f6rg Bjartmarz og Ingvar Alfre\u00f0 Sigf\u00fasson. Inga L\u00e1ra er \u00ed samb\u00fa\u00f0 me\u00f0 \u00a0J\u00f3ni Trausta Sigur\u00f0ssyni \u00fatgefanda og \u00feau eiga \u00ferj\u00fa b\u00f6rn, Fl\u00f3ka Forna 11 \u00e1ra, Ingvar Braga 8 \u00e1ra og Laufeyju Eddu 6 \u00e1ra.<\/p>\n<\/div><\/div>","protected":false},"featured_media":5773,"template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_phd_date_start":"2025-06-27T09:00:00+00:00","_phd_date_end":"2025-06-27T12:00:00+00:00","_phd_location":"A\u00f0albygging H\u00e1t\u00ed\u00f0asalur","_phd_admission":"A\u00f0gangur \u00f3keypis","_phd_thesis_title":"Hjarta- og lungnad\u00e6lur: \u00c1bendingar og snemm- og s\u00ed\u00f0b\u00fainn \u00e1rangur. Extracorporeal membrane oxygenation: Indications and early and late outcome","_phd_source_url":"https:\/\/gamli.hi.is\/vidburdir\/doktorsvorn_i_laeknavisindum_inga_lara_ingvarsdottir","_phd_source_node_id":"441729","_phd_source_type":"vidburdir","_phd_member_id":948,"footnotes":""},"phd_school":[60,67],"phd_discipline":[69],"class_list":["post-6410","phd_defence","type-phd_defence","status-publish","has-post-thumbnail","hentry","phd_school-heilbrigdisvisindasvid","phd_school-laeknadeild","phd_discipline-phd-i-laeknavisindum"],"_links":{"self":[{"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/phd_defence\/6410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/phd_defence"}],"about":[{"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/types\/phd_defence"}],"version-history":[{"count":0,"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/phd_defence\/6410\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/media\/5773"}],"wp:attachment":[{"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/media?parent=6410"}],"wp:term":[{"taxonomy":"phd_school","embeddable":true,"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/phd_school?post=6410"},{"taxonomy":"phd_discipline","embeddable":true,"href":"https:\/\/phd.hi.is\/en\/wp-json\/wp\/v2\/phd_discipline?post=6410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}